New York State Common Retirement Fund
MRTX

New York State Common Retirement Fund’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

New York State Common Retirement Fund’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,200
Closed -$2.36M – 3280
2023
Q4 		$2.36M Sell
40,200
-277,401
-87% -$15.6M ﹤0.01% 1391
2023
Q3 		$13.8M Buy
317,601
+84,741
+36% +$3.03M 0.02% 672
2023
Q2 		$8.41M Buy
232,860
+643
+0.3% +$26.5K 0.01% 966
2023
Q1 		$8.63M Buy
232,217
+835
+0.4% +$37.6K 0.01% 951
2022
Q4 		$10.5M Buy
231,382
+50,650
+28% +$3.28M 0.01% 847
2022
Q3 		$12.6M Sell
180,732
-1,610
-0.9% -$119K 0.02% 737
2022
Q2 		$12.2M Buy
182,342
+63,059
+53% +$4.01M 0.02% 779
2022
Q1 		$9.81M Buy
119,283
+64,480
+118% +$6.59M 0.01% 973
2021
Q4 		$8.04M Buy
54,803
+2,415
+5% +$375K 0.01% 1098
2021
Q3 		$9.27M Buy
52,388
+1,263
+2% +$203K 0.01% 1036
2021
Q2 		$8.26M Buy
51,125
+13,125
+35% +$2.11M 0.01% 1105
2021
Q1 		$6.51M Sell
38,000
-6,930
-15% -$1.37M 0.01% 1149
2020
Q4 		$9.87M Buy
44,930
+4,000
+10% +$865K 0.01% 952
2020
Q3 		$6.8M Buy
40,930
+7,230
+21% +$989K 0.01% 1041
2020
Q2 		$3.85M Buy
33,700
+7,900
+31% +$766K ﹤0.01% 1259
2020
Q1 		$1.98M Buy
25,800
+1,300
+5% +$117K ﹤0.01% 1408
2019
Q4 		$3.16M Sell
24,500
-3,900
-14% -$376K ﹤0.01% 1416
2019
Q3 		$2.21M Buy
28,400
+2,800
+11% +$263K ﹤0.01% 1594
2019
Q2 		$2.64M Buy
25,600
+5,200
+25% +$405K ﹤0.01% 1520
2019
Q1 		$1.5M Hold
20,400
– – ﹤0.01% 1757
2018
Q4 		$865K Sell
20,400
-2,000
-9% -$79.7K ﹤0.01% 1989
2018
Q3 		$1.05M Buy
22,400
+2,200
+11% +$122K ﹤0.01% 2063
2018
Q2 		$996K Buy
+20,200
New +$763K ﹤0.01% 2099
2017
Q2 		– Sell
-11,901
Closed -$62K – 3255
2017
Q1 		$62K Buy
11,901
+1
+0% +$5 ﹤0.01% 3042
2016
Q4 		$57K Hold
11,900
– – ﹤0.01% 3053
2016
Q3 		$79K Hold
11,900
– – ﹤0.01% 3033
2016
Q2 		$65K Hold
11,900
– – ﹤0.01% 3061
2016
Q1 		$255K Hold
11,900
– – ﹤0.01% 2570
2015
Q4 		$376K Buy
11,900
+2,100
+21% +$74.2K ﹤0.01% 2444
2015
Q3 		$337K Sell
9,800
-169
-2% -$5.11K ﹤0.01% 2503
2015
Q2 		$314K Buy
+9,969
New +$294K ﹤0.01% 2736

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund's MRTX Position: Q1 2024 in Review

New York State Common Retirement Fund sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 40,200 shares — an estimated $2.36M sold.

New York State Common Retirement Fund first reported a position in MRTX in Q2 2015 and held it in 31 quarters. The position peaked at $13.8M in Q3 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • New York State Common Retirement Fund reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 40,200 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.36M.
  • New York State Common Retirement Fund first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 31 quarters.
  • New York State Common Retirement Fund's Mirati Therapeutics, Inc. Common Stock position peaked at $13.8M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on New York State Common Retirement Fund's 13F filing for Q1 2024, filed 7 May 2024.